ONCY
Oncolytics Biotech Inc
0.6682$
-0.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +30,999,900.0% | -100.0% | – | +50.0% | +123.3% | +12.0% | -100.0% | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | -94.8% | +1,754.1% | -97.7% | +5,001.7% | -97.3% | +27.2% | +10.1% | -10.1% | -44.1% | +5.1% | +409.1% | -31.5% | +8.4% | -16.5% | -0.8% | -70.9% | -19.5% | |
| – | +30,999,900.0% | -100.0% | – | +50.0% | +123.3% | +12.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +658.2% | +38.7% | -16.3% | -22.6% | +114.5% | +31.0% | +16.0% | +4.7% | +18.0% | -9.0% | +0.3% | +95.6% | +31.7% | -41.1% | -25.3% | -37.8% | +13.6% | -3.9% | +0.3% | +14.9% | +19.7% | -0.2% | -12.0% | +17.4% | +15.7% | -13.8% | |
| – | +1,091.3% | +295.1% | -49.8% | +40.5% | +85.3% | -42.5% | +28.1% | +12.2% | -98.6% | +6,778.5% | -26.2% | -65.0% | -35.8% | -49.0% | +1,241.1% | +2.7% | +4.4% | +15.9% | +16.6% | +31.9% | +30.9% | +2.8% | -36.4% | +44.5% | -14.6% | +52.6% | |
| – | +758.3% | +44.0% | -2.5% | -0.4% | +102.4% | +0.5% | +6.0% | +2.7% | -10.3% | +5.7% | +6.6% | +88.5% | +25.5% | -34.9% | -21.2% | -14.9% | -4.5% | +2.0% | +6.8% | +20.9% | +26.4% | +3.0% | -24.4% | +28.4% | +0.3% | +12.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +281.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +865.3% | -100.5% | – | – | – | – | -67.0% | +425.6% | -23.8% | -82.3% | +25.4% | -53.5% | +197.3% | +1,409.5% | +287.3% | +2,168.0% | -123.8% | – | +26.3% | +18.1% | +29.9% | -16.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.